ARTICLE | Clinical News
Myderison tolperisone regulatory update
November 2, 2009 8:00 AM UTC
EMEA's CHMP said that after an arbitration procedure following a disagreement among EU member states the agency concluded that the benefits did not outweigh the risks for Meditop's Myderison tolperiso...